Performance-enhancing drug use.
According to Gary Green, MD, everyone who deals with athletes is a "stakeholder" in the issue of performance-enhancing drugs and can influence athletes in a positive or negative role. In this issue of ORTHOPEDICS, Dr Green shares his thoughts on testing, prevention, and education of performance-enhancing drug use.
Green
Gary A
GA
Division of Sports Medicine at the David Geffen School of Medicine, University of California-Los Angeles, CA, USA.
D054874:Athletic Performance; D004300:Doping in Sports / Q000331:legislation & jurisprudence* / Q000517:prevention & control*; D006801:Humans; D009985:Orthopedics / Q000331:legislation & jurisprudence*; D015813:Substance Abuse Detection / Q000331:legislation & jurisprudence*; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000517:prevention & control*; D014481:United States